Check Out Novo Integrated Sciences Inc (NVOS)’s Trade Data Rather Than the Analysts’ Views

With 0.69 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.74 shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $0.7499 whereas the lowest price it dropped to was $0.6834. The 52-week range on NVOS shows that it touched its highest point at $5.38 and its lowest point at $0.61 during that stretch. Beta for the stock currently stands at -0.58.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NVOS was down-trending over the past week, with a drop of -6.41%, but this was up by 3.56% over a month. Three-month performance dropped to -57.06% while six-month performance fell -11.73%. The stock lost -42.92% in the past year, while it has lost -11.08% so far this year.

Float and Shares Shorts:

At present, 15.76 million NVOS shares are outstanding with a float of 15.55 million shares on hand for trading. On Jan 31, 2024, short shares totaled 0.62 million, which was 3.51% higher than short shares on Dec 29, 2023. In addition to Mr. Robert Mattacchione as the firm’s Chairman of the Board & CEO, Mr. Christopher Mehlin David serves as its COO, President & Director.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NVOS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Summary of Insider Activity:

Insiders traded NVOS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.